Rivulariaceae Details: NCBI 1185, gram-negative or unknown [family]

| Rivulariaceae| Rivulariaceae Bornet et Flahault 1886

  1. Toxin Production: Some cyanobacteria, including certain species within the family Rivulariaceae, have the potential to produce toxins known as cyanotoxins. These toxins can have adverse effects on the health of humans, animals, and aquatic ecosystems.

  2. Harmful Algal Blooms (HABs): Certain conditions, such as warm temperatures, sunlight, and nutrient-rich environments (eutrophication), can promote the rapid growth and proliferation of cyanobacteria, leading to the formation of harmful algal blooms (HABs). During HABs, cyanobacteria can release toxins into the water, posing a risk to the health of aquatic organisms and humans.

  3. Health Concerns for Humans: Exposure to cyanotoxins through the ingestion, inhalation, or skin contact with contaminated water can result in various health issues for humans. Common symptoms include gastrointestinal problems, skin irritation, respiratory issues, and, in some cases, more severe effects on the liver or nervous system.

  4. Livestock and Wildlife Health: Cyanotoxins can also affect the health of livestock, wildlife, and domestic animals that come into contact with or ingest contaminated water. Livestock deaths have been reported in cases where animals have consumed water containing high levels of cyanotoxins.

  5. Environmental Impact: Beyond health concerns, the proliferation of cyanobacteria, including Rivulariaceae, can have negative environmental impacts. Large-scale algal blooms can lead to oxygen depletion in aquatic ecosystems, negatively affecting fish and other aquatic life.

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

More Information
Statistics NCBI Data Punk End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for Rivulariaceae

These are values that are computed from lab specific samples (Patent Pending)
LabFrequencyUD-LowUD-HighKM LowKM HighLab LowLab HighMean MedianStandard DeviationBox Plot LowBox Plot High KM Percentile Low KM Percentile High
Other Labs 0.53 1 300 0 345 114.1 52 117.8 1 300 7.1 %ile 85.7 %ile
biomesight 41.95 0 20 20 330 0 3419 161.7 30 1661.8 10 90 8 %ile 96 %ile
thorne 6.9 1 3 0 5 2 2 1.4 1 3 25 %ile 50 %ile
thryve 8.03 0 0 1 580 0 165 38.1 25 64.8 11 45 0 %ile 100 %ile

External Reference Ranges for Rivulariaceae

Rivulariaceae (NCBI 1185) per million
Source of Ranges Low Boundary High Boundary Low Boundary %age High Boundary %age
Statistic by Lab Source for Rivulariaceae
These desired values are reported from the lab reports
Lab Frequency Seen Average Standard Deviation Sample Count Lab Samples
BiomeSight 44.783 %   0.014 %  0.148 % 1322.0 2952
CerbaLab 66.667 %   0 %  0 % 2.0 3
es-xenogene 13.793 %   0.026 %  0.004 % 4.0 29
Medivere 85.714 %   0.005 %  0.006 % 6.0 7
Thorne 3.226 %   0 %  0 % 3.0 93
Thryve 7.942 %   0.003 %  0.006 % 110.0 1385

To see medical conditions associated you may be logged in

And display level must be raised above public.


This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.